Do all patients with atrial fibrillation need long-term anticoagulation?

  • Munish Sharma | Department of Internal Medicine, Easton Hospital, Easton, PA, United States.
  • Rohit Masih Department of Internal Medicine, Easton Hospital, Easton, PA, United States.
  • Daniel A.N. Mascarenhas Department of Cardiology, Easton Hospital, Easton, PA, United States.


Atrial fibrillation (AF) is the most common cardiac arrhythmia worldwide with an estimated number of 2.7-6.1 million cases in the United States (US) alone. The incidence of AF is expected to increase 2.5 fold over the next 50 years in the US. The management of AF is complex and includes mainly three aspects; restoration of sinus rhythm, control of ventricular rate and prevention of systemic thromboembolism. AF as a cause of systemic embolization has been well known for many years, and majority of patients are on oral anticoagulants (OACs) to prevent this. Many times, a patient may not be in AF chronically, nor is the AF burden (the amount of time patient is in AF out of the total monitored time) calculated. We present three cases of new onset transient AF triggered by temporary stressors. We were able to restore normal sinus rhythm (NSR) with chemical cardioversion. As per 2014 American College of Cardiology (ACC)/American Heart Association (AHA) recommendations, we started all three patients on OACs based on CHA2DS2VASc score >2. However, the patients refused long term OACs after restoration of NSR and correction of the temporary enticing stressors. In any case, the decision to start OACs would have had its own risks. Here we describe how antiarrhythmic drugs were used to maintain NSR, all while they were continuously monitored to determine the need to continue OACs.


Download data is not yet available.

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Case Reports
Atrial fibrillation, anticoagulation therapy.
Abstract views: 716

PDF: 477
HTML: 284
Share it
How to Cite
Sharma, M., Masih, R., & Mascarenhas, D. A. (2017). Do all patients with atrial fibrillation need long-term anticoagulation?. Clinics and Practice, 7(3).

Most read articles by the same author(s)